Arcutis Biotherapeutics Ownership | Who Owns Arcutis Biotherapeutics?
Arcutis Biotherapeutics Ownership Summary
Arcutis Biotherapeutics is owned by 103.37% institutional investors, 2.15% insiders. Jennison associates is the largest institutional shareholder, holding 9.93% of ARQT shares. Polar Capital Biotech S Inc is the top mutual fund, with 5.55% of its assets in Arcutis Biotherapeutics shares.
ARQT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Arcutis Biotherapeutics | 103.37% | 2.15% | -5.52% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Jennison associates | 12.34M | 9.93% | $171.89M |
Suvretta capital management | 10.00M | 8.10% | $93.04M |
Rubric capital management lp | 9.82M | 7.95% | $91.30M |
Blackrock | 8.62M | 7.76% | $80.19M |
Blackrock funding, inc. /de | 9.15M | 7.36% | $127.44M |
Frazier life sciences management | 8.79M | 7.11% | $81.70M |
Polar capital | 6.88M | 5.57% | $63.98M |
Vanguard group | 6.44M | 5.18% | $89.72M |
State street | 5.13M | 4.62% | $47.75M |
Morgan stanley | 3.97M | 3.22% | $36.95M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Pivotal bioventure partners investment advisor | 2.12M | 19.95% | $29.54M |
Tejara capital | 886.84K | 8.09% | $12.35M |
Frazier life sciences management | 8.79M | 3.82% | $81.70M |
Suvretta capital management | 10.00M | 3.42% | $93.04M |
Rubric capital management lp | 9.82M | 2.39% | $91.30M |
Cormorant asset management, lp | 2.52M | 1.36% | $23.48M |
Two seas capital lp | 762.19K | 1.15% | $7.09M |
Privium fund management b.v. | 325.71K | 1.03% | $4.54M |
Myda advisors | 200.00K | 0.70% | $2.79M |
Fishman jay a ltd/mi | 536.40K | 0.70% | $7.47M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rubric capital management lp | 9.82M | 2.39% | 2.31M |
Suvretta capital management | 10.00M | 3.42% | 2.13M |
Blackrock | 8.62M | 0.00% | 1.96M |
Cercano management | 1.26M | 0.44% | 1.26M |
Eversept partners, lp | 837.85K | 0.53% | 837.85K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
State street | 5.13M | 0.00% | -3.65M |
Farallon capital management | 26.00K | 0.00% | -1.75M |
Braidwell lp | - | - | -1.30M |
Bain capital life sciences investors | - | - | -1.03M |
Franklin resources | 3.31M | 0.01% | -941.10K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Cercano management | 1.26M | 0.44% | 1.26M | $17.49M |
Eversept partners, lp | 837.85K | 0.53% | 837.85K | $7.79M |
Simplify asset management | 742.30K | 0.51% | 742.30K | $10.34M |
Norges bank | 532.79K | 0.00% | 532.79K | $7.42M |
Lazard asset management | 360.00K | 0.00% | 360.00K | $3.35M |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -22.00 |
Byrne asset management | -100.00 |
Colonial trust advisors | -100.00 |
Bessemer group | -110.00 |
Park place capital | -183.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 194 | 1.57% | 128,485,475 | 1.57% | 103 | 0.98% | 104 | -3.70% | 51 | -7.27% |
Jun 30, 2024 | 191 | 13.02% | 126,499,025 | 1.37% | 102 | 0.81% | 108 | -0.92% | 55 | 44.74% |
Mar 31, 2024 | 169 | 24.26% | 124,792,426 | 23.24% | 112 | 0.94% | 109 | 21.11% | 38 | 46.15% |
Dec 31, 2023 | 136 | -4.23% | 101,262,581 | 51.01% | 109 | 0.93% | 90 | 25.00% | 26 | -27.78% |
Sep 30, 2023 | 142 | -3.40% | 67,057,731 | -6.97% | 108 | 0.79% | 72 | -24.21% | 36 | 33.33% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Polar Capital Biotech S Inc | 6.50M | 5.55% | - |
Vanguard Total Stock Mkt Idx Inv | 3.27M | 2.79% | 42.00K |
Jennison SMid Cap Core Equity | 3.09M | 2.64% | - |
PGIM Jennison Small Company A | 3.09M | 2.64% | - |
iShares Russell 2000 ETF | 2.93M | 2.50% | -22.25K |
Jennison Health Sciences Equity | 2.74M | 2.34% | - |
PGIM Jennison Health Sciences Z | 2.74M | 2.34% | - |
SPDR® S&P Biotech ETF | 2.27M | 1.94% | -22.05K |
Franklin Biotechnology Discv A(acc)USD | 2.05M | 1.75% | -603.60K |
Vanguard Institutional Extnd Mkt Idx Tr | 1.58M | 1.35% | -31.06K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 03, 2025 | Matsuda Masaru | See Remarks | Sell | $105.89K |
Feb 03, 2025 | Watanabe Todd Franklin | See Remarks | Sell | $245.12K |
Feb 03, 2025 | Welgus Howard G. | - | Sell | $127.10K |
Feb 03, 2025 | Burnett Patrick | See Remarks | Sell | $153.87K |
Feb 03, 2025 | Edwards Larry Todd | See Remarks | Sell | $27.60K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 6 |
2024 Q4 | 3 | 14 |
2024 Q3 | - | 9 |
2024 Q2 | - | 10 |
2024 Q1 | 1 | 6 |
ARQT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools